Mechanistically, on one hand, CPT2 deficiency increases oleoylcarnitine accumulation to motivate STAT3 pathway and cell proliferation, and on the other hand, CPT2 deficiency hinders Src-mediated JNK activation to resist lipotoxicity induced by lipid-rich environment in HCC.33 Here, CPT2 is linked to hepatocellular carcinoma.